slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
38.350 KRW | +1,99% | +0,26% | -1,67% |
Vakgebied
Aantal werknemers: 45
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
BNF
100,0
%
| 30 726 | 100,0 % | 31 721 | 100,0 % | +3,24% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
100,0
%
| 30 726 | 100,0 % | 31 721 | 100,0 % | +3,24% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dong-Hyun Park
FOU | Founder | 67 | 25-09-02 |
James L. Yeager
CTO | Chief Tech/Sci/R&D Officer | 78 | 01-01-05 |
Bill Breitenbach
PRN | Corporate Officer/Principal | - | 01-06-21 |
Dae-Shick Oh
AUD | Comptroller/Controller/Auditor | 69 | 29-03-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mitchell Steiner
BRD | Director/Board Member | 63 | - |
Dong-Hyun Park
FOU | Founder | 67 | 25-09-02 |
James L. Yeager
CTO | Chief Tech/Sci/R&D Officer | 78 | 01-01-05 |
Peter J. Manso
BRD | Director/Board Member | 70 | - |
Jae-Seung Baek
BRD | Director/Board Member | 71 | 18-03-16 |
Bon-Gwon Gu
BRD | Director/Board Member | 57 | - |
Jeong-Seok Chae
BRD | Director/Board Member | 68 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 29 699 621 | 21 201 688 ( 71,39 %) | 0 | 71,39 % |
Bedrijfsgegevens
Mezzion Pharma Co., Ltd.
7th Floor, Seokcheon Building 570, Samseong-ro
06163, Seoul
+
http://www.mezzion.co.krSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,67% | 815 mln. | |
+5,48% | 69,91 mld. | |
+12,55% | 9,24 mld. | |
-13,75% | 5,05 mld. | |
+42,38% | 4,47 mld. | |
+4,51% | 3,92 mld. | |
-19,05% | 2,41 mld. | |
-28,72% | 2,23 mld. | |
+11,13% | 2,02 mld. | |
+5,04% | 1,66 mld. |
- Beurs
- Aandelen
- Koers A140410
- Onderneming Mezzion Pharma Co.,Ltd.